UNSPSC 51422202: Fluorometholone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SV0CSG527L, chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)- but generally known as fluorometholone, which bears US NIH Compound Identifier 3384. European Medicines Agency schedules Fluorometholone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07720MIG.

UNSPSC 51422202 Fluorometholone is a Commodity code that reflects pharmaceutical procurement, yet the single recent state and local opportunity posted under it shows a clear mismatch: Seminole County, Florida issued an IFB for naloxone and drug deactivation systems rather than fluorometholone ophthalmic suspension. The code shows minimal relevant recent activity aligned with its nominal pharmaceutical scope. State and local purchasing offices appear to use this code infrequently or with inconsistent taxonomy mapping, and the available opportunity does not reflect the dermatological or ophthalmic anti-inflammatory agent the code nominally describes.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, for procurement of 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option and includes standard compliance requirements such as E-Verify certification, drug-free workplace attestation, and commercial general liability and workers' compensation insurance. Bidders must include all shipping and delivery costs in their proposals and submit bids electronically through the county's e-Procurement Portal. The procurement does not designate set-asides for disadvantaged enterprises.